Velarion Records
Free. Unsubscribe any time.

Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics, Inc. filed 35 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 73 transactions and 578,956 shares. None carries the SEC's AFF10B5ONE flag; all 35 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Maze Therapeutics, Inc. 73

Adoption dates in Maze Therapeutics, Inc. 2

Results prints in Maze Therapeutics, Inc. 0

Trades before a print in Maze Therapeutics, Inc. 0

Interval to Maze Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Maze Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on February 6, 2026”

Sources: SEC EDGAR full-text search and the SEC submissions API.